AXGN Maintains Overweight by Barclays -- Price Target Lowered to $50
gurufocus.com · 2026-10-23
Axogen Inc (AXGN) Analyst Rating Update On October 12, 2023, Barclays maintained an Overweight rating for Axogen (AXGN). However, the price target has been a
Read the full story at gurufocus.com →
Is AXGN undervalued? See TickrTrends' fair value analysis →